NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 81 filers reported holding NEVRO CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,628,000 | -18.8% | 16,288 | -4.5% | 0.51% | +14.7% |
| Q4 2019 | $2,005,000 | -43.0% | 17,055 | -49.4% | 0.44% | -6.6% |
| Q3 2016 | $3,516,000 | +37.9% | 33,683 | -2.5% | 0.47% | +23.2% |
| Q2 2016 | $2,549,000 | +36.6% | 34,558 | +4.2% | 0.38% | +31.2% |
| Q1 2016 | $1,866,000 | -53.7% | 33,171 | -44.4% | 0.29% | -44.6% |
| Q4 2015 | $4,027,000 | +43.0% | 59,652 | -1.7% | 0.53% | +18.2% |
| Q3 2015 | $2,816,000 | -45.9% | 60,695 | -37.3% | 0.45% | -26.8% |
| Q2 2015 | $5,205,000 | +6.7% | 96,829 | -4.8% | 0.61% | +8.2% |
| Q1 2015 | $4,876,000 | +332.3% | 101,739 | +248.9% | 0.56% | +258.6% |
| Q4 2014 | $1,128,000 | – | 29,164 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |